Sabre Insurance Group PLC
05 August 2026
5 August 2026
Sabre Insurance Group plc
("Sabre" or the "Company")
Completion of Buyback Programme
On 2 June 2026, Sabre Insurance Group plc announced an on-market share buyback programme to purchase up to a maximum aggregate consideration of £5 million (the "Buyback Programme"), in accordance with the authority given by its shareholders at its Annual General Meeting on 21 May 2026. The Buyback Programme commenced on 2 June 2026.
The Company confirms that, having repurchased 2,870,000 Ordinary Shares in the capital of the Company ("Ordinary Shares") for a total consideration of £5.0 million, the Buyback Programme is now complete. The average price of Ordinary Shares bought back under the Buyback Programme was 174.05 pence per Ordinary Share.
Following cancellation of the above Ordinary Shares, the Company's issued and fully paid share capital will consist of 243,730,000 Ordinary Shares with a nominal value of £0.001 each, with one voting right per share. The Company does not hold any Ordinary Shares in Treasury.
The total number of voting rights in the Company once the cancellation process has been completed will therefore be 243,730,000.
For further information, please contact:
|
Investor enquiries |
01306 747 272 |
|
Sabre Insurance Group plc |
investor.relations@sabre.co.uk |
|
Media enquiries |
020 7260 2700 |
|
Teneo |
sabre@teneo.com |
|
James Macey White / Ffion Dash |
LEI Code: 2138006RXRQ8P8VKGV98
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.